Abnormal p53 immunoreactivity and prognosis in node-negative breast carcinomas with long-term follow-up

Silvano Bosari, Arthur K C Lee, Giuseppe Viale, Gerald J. Heatley, Guido Coggi

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

The expression of the p53 gene product was investigated immunocytochemically in a retrospective series of 164 formalin-fixed paraffin-embedded invasive breast carcinomas with pathologically proven negative lymph nodes. Overall, 78 tumors (48%) showed a variable degree of p53 immunoreactivity. Among these, 38 cases were low expressors (1-10%p53 immunoreactive tumor cells), 21 moderate expressors (10-50% immunoreactive cells) and 19 high expressors (> 50% immunoreactive cells). Abnormal p53 expression correlated significantly with tumor size, histological and nuclear grade, DNA ploidy, mitotic rate and proliferation index, and with the lack of estrogen receptors. Disease-free and adjusted survival analysis of the 124 node-negative patients with long term (more than 10 years) follow-up, however, did not reveal an independent prognostic role for p53 expression. These data suggest that the evaluation of p53 immunoreactivity may only play a role in a multiparametric prognostic assessment of node-negative breast carcinoma.

Original languageEnglish
Pages (from-to)291-295
Number of pages5
JournalVirchows Archiv A Pathological Anatomy and Histopathology
Volume421
Issue number4
DOIs
Publication statusPublished - Jul 1992

Fingerprint

Breast Neoplasms
Neoplasms
Ploidies
p53 Genes
Survival Analysis
Estrogen Receptors
Paraffin
Formaldehyde
Disease-Free Survival
Lymph Nodes
DNA

Keywords

  • Breast carcinoma
  • Immunocytochemistry
  • p53 gene
  • Prognosis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Anatomy

Cite this

Abnormal p53 immunoreactivity and prognosis in node-negative breast carcinomas with long-term follow-up. / Bosari, Silvano; Lee, Arthur K C; Viale, Giuseppe; Heatley, Gerald J.; Coggi, Guido.

In: Virchows Archiv A Pathological Anatomy and Histopathology, Vol. 421, No. 4, 07.1992, p. 291-295.

Research output: Contribution to journalArticle

@article{3dd9d4b2636c4106987797f671d8bdf5,
title = "Abnormal p53 immunoreactivity and prognosis in node-negative breast carcinomas with long-term follow-up",
abstract = "The expression of the p53 gene product was investigated immunocytochemically in a retrospective series of 164 formalin-fixed paraffin-embedded invasive breast carcinomas with pathologically proven negative lymph nodes. Overall, 78 tumors (48{\%}) showed a variable degree of p53 immunoreactivity. Among these, 38 cases were low expressors (1-10{\%}p53 immunoreactive tumor cells), 21 moderate expressors (10-50{\%} immunoreactive cells) and 19 high expressors (> 50{\%} immunoreactive cells). Abnormal p53 expression correlated significantly with tumor size, histological and nuclear grade, DNA ploidy, mitotic rate and proliferation index, and with the lack of estrogen receptors. Disease-free and adjusted survival analysis of the 124 node-negative patients with long term (more than 10 years) follow-up, however, did not reveal an independent prognostic role for p53 expression. These data suggest that the evaluation of p53 immunoreactivity may only play a role in a multiparametric prognostic assessment of node-negative breast carcinoma.",
keywords = "Breast carcinoma, Immunocytochemistry, p53 gene, Prognosis",
author = "Silvano Bosari and Lee, {Arthur K C} and Giuseppe Viale and Heatley, {Gerald J.} and Guido Coggi",
year = "1992",
month = "7",
doi = "10.1007/BF01660975",
language = "English",
volume = "421",
pages = "291--295",
journal = "Virchows Archiv - A Pathological Anatomy and Histopathology",
issn = "0945-6317",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Abnormal p53 immunoreactivity and prognosis in node-negative breast carcinomas with long-term follow-up

AU - Bosari, Silvano

AU - Lee, Arthur K C

AU - Viale, Giuseppe

AU - Heatley, Gerald J.

AU - Coggi, Guido

PY - 1992/7

Y1 - 1992/7

N2 - The expression of the p53 gene product was investigated immunocytochemically in a retrospective series of 164 formalin-fixed paraffin-embedded invasive breast carcinomas with pathologically proven negative lymph nodes. Overall, 78 tumors (48%) showed a variable degree of p53 immunoreactivity. Among these, 38 cases were low expressors (1-10%p53 immunoreactive tumor cells), 21 moderate expressors (10-50% immunoreactive cells) and 19 high expressors (> 50% immunoreactive cells). Abnormal p53 expression correlated significantly with tumor size, histological and nuclear grade, DNA ploidy, mitotic rate and proliferation index, and with the lack of estrogen receptors. Disease-free and adjusted survival analysis of the 124 node-negative patients with long term (more than 10 years) follow-up, however, did not reveal an independent prognostic role for p53 expression. These data suggest that the evaluation of p53 immunoreactivity may only play a role in a multiparametric prognostic assessment of node-negative breast carcinoma.

AB - The expression of the p53 gene product was investigated immunocytochemically in a retrospective series of 164 formalin-fixed paraffin-embedded invasive breast carcinomas with pathologically proven negative lymph nodes. Overall, 78 tumors (48%) showed a variable degree of p53 immunoreactivity. Among these, 38 cases were low expressors (1-10%p53 immunoreactive tumor cells), 21 moderate expressors (10-50% immunoreactive cells) and 19 high expressors (> 50% immunoreactive cells). Abnormal p53 expression correlated significantly with tumor size, histological and nuclear grade, DNA ploidy, mitotic rate and proliferation index, and with the lack of estrogen receptors. Disease-free and adjusted survival analysis of the 124 node-negative patients with long term (more than 10 years) follow-up, however, did not reveal an independent prognostic role for p53 expression. These data suggest that the evaluation of p53 immunoreactivity may only play a role in a multiparametric prognostic assessment of node-negative breast carcinoma.

KW - Breast carcinoma

KW - Immunocytochemistry

KW - p53 gene

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=0026471731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026471731&partnerID=8YFLogxK

U2 - 10.1007/BF01660975

DO - 10.1007/BF01660975

M3 - Article

VL - 421

SP - 291

EP - 295

JO - Virchows Archiv - A Pathological Anatomy and Histopathology

JF - Virchows Archiv - A Pathological Anatomy and Histopathology

SN - 0945-6317

IS - 4

ER -